AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
THE MODE OF CELL-DEATH IN A LUNG-CANCER CELL-LINE CULTURED WITH INHIBITORS OF 5-LIPOXYGENASE OR THE FREE-RADICAL SPIN TRAP, NTBN
Authors: OU D BONOMI P HARRIS JE ANDERSON KM
Citation: D. Ou et al., THE MODE OF CELL-DEATH IN A LUNG-CANCER CELL-LINE CULTURED WITH INHIBITORS OF 5-LIPOXYGENASE OR THE FREE-RADICAL SPIN TRAP, NTBN, The FASEB journal, 12(4), 1998, pp. 783-783
RECENT ADVANCES WITH CHEMOTHERAPY FOR NSCLC - THE ECOG EXPERIENCE
Authors: JOHNSON DH CHANG AY ETTINGER DS KIM KM BONOMI P
Citation: Dh. Johnson et al., RECENT ADVANCES WITH CHEMOTHERAPY FOR NSCLC - THE ECOG EXPERIENCE, Oncology, 12(1), 1998, pp. 67-70
INHIBITION OF CANCER CELL-PROLIFERATION BY DISRUPTION OF INTERDIGITATED CONCATENATED HIERARCHIES OF METABOLIC CONTROL/IMPLEMENTATION PROCESSES - A PROPOSAL/
Authors: ANDERSON KM BONOMI P MENG J HARRIS JE
Citation: Km. Anderson et al., INHIBITION OF CANCER CELL-PROLIFERATION BY DISRUPTION OF INTERDIGITATED CONCATENATED HIERARCHIES OF METABOLIC CONTROL/IMPLEMENTATION PROCESSES - A PROPOSAL/, Medical hypotheses, 50(2), 1998, pp. 119-123
COMPARISON OF SEVERAL MODEL-BASED METHODS FOR ANALYZING INCOMPLETE QUALITY-OF-LIFE DATA IN CANCER CLINICAL-TRIALS
Authors: FAIRCLOUGH DL PETERSON HF CELLA D BONOMI P
Citation: Dl. Fairclough et al., COMPARISON OF SEVERAL MODEL-BASED METHODS FOR ANALYZING INCOMPLETE QUALITY-OF-LIFE DATA IN CANCER CLINICAL-TRIALS, Statistics in medicine, 17(5-7), 1998, pp. 781-796
REVIEW OF SELECTED RANDOMIZED TRIALS IN SMALL-CELL LUNG-CANCER
Authors: BONOMI P
Citation: P. Bonomi, REVIEW OF SELECTED RANDOMIZED TRIALS IN SMALL-CELL LUNG-CANCER, Seminars in oncology, 25(4), 1998, pp. 70-78
EASTERN-COOPERATIVE-ONCOLOGY-GROUP EXPERIENCE WITH CHEMOTHERAPY IN ADVANCED NONSMALL CELL LUNG-CANCER
Authors: BONOMI P
Citation: P. Bonomi, EASTERN-COOPERATIVE-ONCOLOGY-GROUP EXPERIENCE WITH CHEMOTHERAPY IN ADVANCED NONSMALL CELL LUNG-CANCER, Chest, 113(1), 1998, pp. 13-16
A RANDOMIZED PHASE-II TRIAL OF ECHINOMYCIN, TRIMETREXATE, AND CISPLATIN PLUS ETOPOSIDE IN PATIENTS WITH METASTATIC NONSMALL CELL LUNG-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (E1587)
Authors: CHANG AY KIM K BOUCHER H BONOMI P STEWART JA KARP DD BLUM RH
Citation: Ay. Chang et al., A RANDOMIZED PHASE-II TRIAL OF ECHINOMYCIN, TRIMETREXATE, AND CISPLATIN PLUS ETOPOSIDE IN PATIENTS WITH METASTATIC NONSMALL CELL LUNG-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (E1587), Cancer, 82(2), 1998, pp. 292-300
COMMUNICATION DIFFERENCES BETWEEN PHYSICIANS AND THEIR PATIENTS IN ANONCOLOGY SETTING
Authors: SHER TG CELLA D LESLIE WT BONOMI P TAYLOR SG SERAFIAN B
Citation: Tg. Sher et al., COMMUNICATION DIFFERENCES BETWEEN PHYSICIANS AND THEIR PATIENTS IN ANONCOLOGY SETTING, Journal of clinical psychology in medical settings, 4(3), 1997, pp. 281-293
ESCALATING DOSES OF PACLITAXEL COMBINED WITH CARBOPLATIN ETOPOSIDE AND THORACIC RADIOTHERAPY AS PREOPERATIVE OR DEFINITIVE TREATMENT FOR STAGE-III NONSMALL CELL LUNG-CANCER/
Authors: BONOMI P SIDDIQUI S LINCOLN S SHARMA M RECINE D WARREN W FABER LP
Citation: P. Bonomi et al., ESCALATING DOSES OF PACLITAXEL COMBINED WITH CARBOPLATIN ETOPOSIDE AND THORACIC RADIOTHERAPY AS PREOPERATIVE OR DEFINITIVE TREATMENT FOR STAGE-III NONSMALL CELL LUNG-CANCER/, Seminars in radiation oncology, 7(2), 1997, pp. 1-5
A 5-LIPOXYGENASE INHIBITOR AT MICROMOLAR CONCENTRATION RAISES INTRACELLULAR CALCIUM IN U937 CELLS PRIOR TO THEIR PHYSIOLOGICAL CELL-DEATH
Authors: BUYN T DUDEJA P HARRIS JE OU D SEED T SAWLANI D MENG J BONOMI P ANDERSON KM
Citation: T. Buyn et al., A 5-LIPOXYGENASE INHIBITOR AT MICROMOLAR CONCENTRATION RAISES INTRACELLULAR CALCIUM IN U937 CELLS PRIOR TO THEIR PHYSIOLOGICAL CELL-DEATH, Prostaglandins, leukotrienes and essential fatty acids, 56(1), 1997, pp. 69-77
REGROWTH RESISTANCE AS A LIKELY SIGNIFICANT CONTRIBUTOR TO TREATMENT FAILURE IN DRUG-SENSITIVE NEOPLASTIC DISEASES
Authors: PREISLER HD RAZA A BONOMI P TAYLOR S LAFOLETTE S LESLIE W LINCOLN S
Citation: Hd. Preisler et al., REGROWTH RESISTANCE AS A LIKELY SIGNIFICANT CONTRIBUTOR TO TREATMENT FAILURE IN DRUG-SENSITIVE NEOPLASTIC DISEASES, Cancer investigation, 15(4), 1997, pp. 358-368
POSTOPERATIVE ADJUVANT THERAPY FOR NON-SMALL-CELL LUNG-CANCER
Authors: JOHNSON D ARRIAGADA R BARTHELEMY N BONNER J BONOMI P ENAMI B MINATEL E PARK K QUOIX E VANHOUTTE P
Citation: D. Johnson et al., POSTOPERATIVE ADJUVANT THERAPY FOR NON-SMALL-CELL LUNG-CANCER, Lung cancer, 17, 1997, pp. 23-25
POSTOPERATIVE BRONCHOPULMONARY COMPLICATIONS IN STAGE-III LUNG-CANCERPATIENTS TREATED WITH PREOPERATIVE PACLITAXEL-CONTAINING CHEMOTHERAPYAND CONCURRENT RADIATION
Authors: BONOMI P FABER LP WARREN W LINCOLN S LAFOLLETTE S SHARMA M RECINE D
Citation: P. Bonomi et al., POSTOPERATIVE BRONCHOPULMONARY COMPLICATIONS IN STAGE-III LUNG-CANCERPATIENTS TREATED WITH PREOPERATIVE PACLITAXEL-CONTAINING CHEMOTHERAPYAND CONCURRENT RADIATION, Seminars in oncology, 24(4), 1997, pp. 123-129
CHEMOTHERAPY FOR STAGE-IV NONSMALL CELL LUNG-CANCER - PROTOCOL VERSUSNONPROTOCOL - IS NONINVESTIGATIONAL TREATMENT WORTHWHILE - PATIENT SELECTION - WHICH REGIMEN - WHATS NEXT
Authors: BONOMI P
Citation: P. Bonomi, CHEMOTHERAPY FOR STAGE-IV NONSMALL CELL LUNG-CANCER - PROTOCOL VERSUSNONPROTOCOL - IS NONINVESTIGATIONAL TREATMENT WORTHWHILE - PATIENT SELECTION - WHICH REGIMEN - WHATS NEXT, Seminars in radiation oncology, 6(2), 1996, pp. 110-117
DOES AN INABILITY TO ERADICATE NORMAL STEM-CELLS PRECLUDE THE CURE OFSOME CANCERS
Authors: ANDERSON KM BONOMI P HARRIS JE
Citation: Km. Anderson et al., DOES AN INABILITY TO ERADICATE NORMAL STEM-CELLS PRECLUDE THE CURE OFSOME CANCERS, Medical hypotheses, 47(1), 1996, pp. 31-34
AN IN-VIVO INHIBITOR OF 5-LIPOXYGENASE, MK886, AT MICROMOLAR CONCENTRATION INDUCES APOPTOSIS IN U937 AND CML CELLS
Authors: ANDERSON KM SEED T JAJEH A DUDEJA P BYUN T MENG J OU D BONOMI P HARRIS JE
Citation: Km. Anderson et al., AN IN-VIVO INHIBITOR OF 5-LIPOXYGENASE, MK886, AT MICROMOLAR CONCENTRATION INDUCES APOPTOSIS IN U937 AND CML CELLS, Anticancer research, 16(5A), 1996, pp. 2589-2599
ESCALATING PACLITAXEL DOSES COMBINED WITH CARBOPLATIN ETOPOSIDE AND THORACIC RADIOTHERAPY AS PREOPERATIVE OR DEFINITIVE TREATMENT FOR STAGE-III NONSMALL CELL LUNG-CANCER/
Authors: BONOMI P SIDDIQUI S LINCOLN S SHARMA M RECINE D WARREN W FABER LP
Citation: P. Bonomi et al., ESCALATING PACLITAXEL DOSES COMBINED WITH CARBOPLATIN ETOPOSIDE AND THORACIC RADIOTHERAPY AS PREOPERATIVE OR DEFINITIVE TREATMENT FOR STAGE-III NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 23(6), 1996, pp. 102-107
DISCUSSION - LUNG-CANCER
Authors: CARNEY DN BUNN PA BELANI CP",GIACCONE,"SHEPHERD FA CALVERT AH COMIS RL SPLINTER TAW ETTINGER DS JOHNSON DH LANGER CJ GRECO FA HAINSWORTH JD BONOMI P CURRAN WJ CHOY H GLANTZ MJ
Citation: Dn. Carney et al., DISCUSSION - LUNG-CANCER, Seminars in oncology, 23(6), 1996, pp. 140-147
FADROZOLE HCL (CGS-16949A) VERSUS MEGESTROL-ACETATE TREATMENT OF POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CARCINOMA - RESULTS OF 2 RANDOMIZED DOUBLE-BLIND CONTROLLED MULTIINSTITUTIONAL TRIALS
Authors: BUZDAR AU SMITH R VOGEL C BONOMI P KELLER AM FAVIS G MULAGHA M COOPER J
Citation: Au. Buzdar et al., FADROZOLE HCL (CGS-16949A) VERSUS MEGESTROL-ACETATE TREATMENT OF POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CARCINOMA - RESULTS OF 2 RANDOMIZED DOUBLE-BLIND CONTROLLED MULTIINSTITUTIONAL TRIALS, Cancer, 77(12), 1996, pp. 2503-2513
RELIABILITY AND VALIDITY OF THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY - LUNG (FACT-L) QUALITY-OF-LIFE INSTRUMENT
Authors: CELLA DF BONOMI AE LLOYD SR TULSKY DS KAPLAN E BONOMI P
Citation: Df. Cella et al., RELIABILITY AND VALIDITY OF THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY - LUNG (FACT-L) QUALITY-OF-LIFE INSTRUMENT, Lung cancer, 12(3), 1995, pp. 199-220
COMBINED-MODALITY TREATMENT FOR STAGE-III NONSMALL CELL LUNG-CANCER
Authors: BONOMI P
Citation: P. Bonomi, COMBINED-MODALITY TREATMENT FOR STAGE-III NONSMALL CELL LUNG-CANCER, Lung cancer, 12, 1995, pp. 41-52
PHASE-II TRIAL OF GALLIUM NITRATE, AMONAFIDE AND TENIPOSIDE IN METASTATIC NON-SMALL-CELL LUNG-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (E2588)
Authors: CHANG AY TU ZN SMITH JL BONOMI P SMITH TJ WIERNIK PH BLUM R
Citation: Ay. Chang et al., PHASE-II TRIAL OF GALLIUM NITRATE, AMONAFIDE AND TENIPOSIDE IN METASTATIC NON-SMALL-CELL LUNG-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (E2588), Investigational new drugs, 13(2), 1995, pp. 137-141
CARBOPLATIN ETOPOSIDE RADIATION PLUS ESCALATING DOSES OF PACLITAXEL IN STAGE-III NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT
Authors: BONOMI P FABER LP RECINE D LINCOLN S
Citation: P. Bonomi et al., CARBOPLATIN ETOPOSIDE RADIATION PLUS ESCALATING DOSES OF PACLITAXEL IN STAGE-III NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT, Seminars in oncology, 22(4), 1995, pp. 42-47
ALTERATION OF INTEGRATED OPTICAL-DENSITY AND INTERCELLULAR STRUCTURE AFTER INDUCTION CHEMOTHERAPY AND SURVIVAL IN LUNG-CARCINOMA PATIENTS TREATED SURGICALLY
Authors: KAYSER K LIEWALD F KREMER K TACKE M STORCK M FABER P BONOMI P
Citation: K. Kayser et al., ALTERATION OF INTEGRATED OPTICAL-DENSITY AND INTERCELLULAR STRUCTURE AFTER INDUCTION CHEMOTHERAPY AND SURVIVAL IN LUNG-CARCINOMA PATIENTS TREATED SURGICALLY, Analytical and quantitative cytology and histology, 16(1), 1994, pp. 18-24
POTENTIAL APPLICATIONS OF APOPTOSIS IN MODIFYING THE BIOLOGICAL BEHAVIOR OF THERAPEUTICALLY REFRACTORY CANCERS
Authors: ANDERSON KM HARRIS JE BONOMI P
Citation: Km. Anderson et al., POTENTIAL APPLICATIONS OF APOPTOSIS IN MODIFYING THE BIOLOGICAL BEHAVIOR OF THERAPEUTICALLY REFRACTORY CANCERS, Medical hypotheses, 43(4), 1994, pp. 207-213
Risultati: 1-25 | 26-30